卵巢动脉参与盆腔肿瘤供血的介入治疗

Endovascular interventional management of ovarian arteries to supplement of pelvis neoplasm

  • 摘要: 目的:评价经导管栓塞卵巢动脉(OA)参与盆腔肿瘤的疗效和安全性。方法:对30例OA参与盆腔肿瘤供血的患者进行了选择性OA栓塞或栓塞化疗术,在栓塞OA之前均做过常规髂内动脉前支-子宫动脉栓塞化疗或栓塞术。结果:选择性栓塞OA的技术成功率为100%,包括栓塞两侧OA者3例、单侧者27例,未发生与栓塞术相关的并发症,6例阴道出血患者补充栓塞OA后出血立即停止,18例术后肿瘤明显缩小,6例无显著变化。2例出现一过性卵巢功能减退症状、分别于术后3、4个月自行恢复正常。结论:OA可参与盆腔肿瘤的供血,是导致常规栓塞两侧髂内动脉-子宫动脉疗效不佳的原因之一。如发现OA参与盆腔肿瘤的供血,补充做OA栓塞术是安全和有效的。

     

    Abstract: Objective:To evaluate the effect and safety of transcatheter arterial embolization(TAE)of the ovarian arteries(OA) that supply to the pelvis neoplasm.Methods: TAE or transcatheter arterial chemoembolization of OA was performed supplementally in 30 patients whose OA supplying to the pelvis neoplasm.Routine hypogastric-uterine arterial chemoembolization or embolization was performed before TAE of OA.Results: Technical success of OA embolization was achieved in all 30 cases including bilateral OA embolization in 3 patients,and unilateral OA embolization in 27 patients,without severe complications related to the procedure.Six paients' bleeding from the vagina ceased immediately after supplemental OA embolization.Eighteen patients' pelvis neoplasm decreased obviously after the OA embolization and six patients' pelvis neoplasm had no obvious changes.Two patients developed transient symptoms of ovarian dysfunction after the OA embolization and their menstruation became normal after 3 months and 4 months without cure.Conclusion: Pelvis neoplasm can be supplied by OA.It is one of the reasons that curative treatment of pelvis neoplasm is not effective by routine hypogastric-uterine arterial chemoembolization or embolization.Supplemental TAE of OA is a safe and effective method in the management of pelvis neoplasm supplied by OA.

     

/

返回文章
返回